LANIA, ANDREA GERARDO ANTONIO
LANIA, ANDREA GERARDO ANTONIO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
2023 S. Piccini, G. Favacchio, C. Panico, E. Morenghi, F. Folli, G. Mazziotti, A.G. Lania, M. Mirani
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
2022 F. Mangili, E. Esposito, D. Treppiedi, R. Catalano, G. Marra, G. Di Muro, A.M. Barbieri, M. Locatelli, A.G. Lania, A. Mangone, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial
2022 S. Partelli, S. Massironi, A. Zerbi, P. Niccoli, W. Kwon, L. Landoni, F. Panzuto, A. Tomazic, A. Bongiovanni, G. Kaltsas, A. Sauvanet, E. Bertani, V. Mazzaferro, M. Caplin, T. Armstrong, M.O. Weickert, J. Ramage, E. Segelov, G. Butturini, S. Staettner, M. Cives, A. Frilling, C.A. Moulton, J. He, F. Boesch, A. Selberheer, O. Twito, A. Castaldi, C.G. De Angelis, S. Gaujoux, K. Holzer, C.H. Wilson, H. Almeamar, E. Vigia, F. Muffatti, M. Lucà, A. Lania, J. Ewald, H. Kim, R. Salvia, M. Rinzivillo, A. Smid, A. Gardini, M. Tsoli, O. Hentic, S. Colombo, D. Citterio, C. Toumpanakis, E. Ramsey, H.S. Randeva, R. Srirajaskanthan, D. Croagh, P. Regi, S. Gasteiger, P. Invernizzi, C. Ridolfi, M. Giovannini, J.Y. Jang, C. Bassi, M. Falconi
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project
2021 M.E. Cazzaniga, M. Giordano, M. Bandera, C. Cassani, V. Bounous, A. Lania, G. Biasi, M. Destro, S. Ricci, D. Lucini, N. Biglia, O. Pagani
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors
2021 F. Mangili, E. Giardino, D. Treppiedi, A.M. Barbieri, R. Catalano, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study
2020 G. Mazziotti, C. Battista, F. Maffezzoni, S. Chiloiro, E. Ferrante, N. Prencipe, L. Grasso, F. Gatto, R. Olivetti, M. Arosio, M. Barale, A. Bianchi, M. Cellini, I. Chiodini, L. De Marinis, G. Del Sindaco, C. Di Somma, A. Ferlin, E. Ghigo, A. Giampietro, S. Grottoli, E. Lavezzi, G. Mantovani, E. Morenghi, R. Pivonello, T. Porcelli, M. Procopio, F. Pugliese, A. Scillitani, A.G. Lania
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells
2020 D. Treppiedi, F. Mangili, E. Giardino, R. Catalano, M. Locatelli, A. Lania, A. Spada, M. Arosio, D. Calebiro, G. Mantovani, E. Peverelli
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells
2018 E. Peverelli, E. Giardino, F. Mangili, D. Treppiedi, R. Catalano, E. Ferrante, E. Sala, M. Locatelli, A.G. Lania, M. Arosio, A. Spada, G. Mantovani
Focus on GH deficiency and thyroid function
2017 C. Giavoli, E. Profka, G. Rodari, A. Lania, P. Beck-Peccoz
Central hypothyroidism - a neglected thyroid disorder
2017 P. Beck-Peccoz, G. Rodari, C. Giavoli, A. Lania
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression
2017 E. Vitali, I. Boemi, L. Rosso, V. Cambiaghi, P. Novellis, G. Mantovani, A. Spada, M. Alloisio, G. Veronesi, S. Ferrero, A.G. Lania
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation
2016 E. Peverelli, E. Giardino, D. Treppiedi, M. Locatelli, V. Vaira, S. Ferrero, S. Bosari, A.G. Lania, A. Spada, G. Mantovani
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review
2016 A. Del Gobbo, E. Peverelli, D. Treppiedi, A. Lania, G. Mantovani, S. Ferrero
Dopamine and somatostatin analogues resistance of pituitary tumors : focus on cytoskeleton involvement
2015 E. Peverelli, D. Treppiedi, E. Giardino, E. Vitali, A.G. Lania, G. Mantovani
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma
2015 A. Toini, A. Dolci, E. Ferrante, E. Verrua, E. Malchiodi, E. Sala, A.G. Lania, I. Chiodini, P. Beck-Peccoz, M. Arosio, A. Spada, G. Mantovani
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues
2014 S. Ferrero, V. Vaira, A. Del Gobbo, L. Vicentini, S. Bosari, P. Beck-Peccoz, G. Mantovani, A. Spada, A.G. Lania
Diagnostic features and outcome of surgical therapy of acromegalic patients : experience of the last three decades
2014 E. Sala, E. Ferrante, M. Locatelli, P. Rampini, G. Mantovani, C. Giavoli, M. Filopanti, E. Verrua, E. Malchiodi, G. Carrabba, M. Arosio, P. Beck-Peccoz, A. Spada, A.G. Lania
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation
2014 E. Peverelli, E. Giardino, E. Vitali, D. Treppiedi, A.G. Lania, G. Mantovani
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
2014 C. Giavoli, E. Profka, E. Sala, M. Filopanti, A.M. Barbieri, S. Bergamaschi, E. Ferrante, M. Arosio, B. Ambrosi, A.G. Lania, A. Spada, P. Beck-Peccoz
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients
2014 M. Filopanti, A.M. Barbieri, G. Mantovani, S. Corbetta, V. Gasco, M. Ragonese, C. Martini, F. Bogazzi, A. Colao, D. Ferone, A. Peri, F. Pigliaru, G. Angeletti, M. Arosio, P. Beck-Peccoz, A.G. Lania, A. Spada